Navigation Links
ASCO Interview of MD Anderson's Mittendorf on AE37 Breast Cancer Vaccine Now Available on Generex Websites
Date:6/13/2013

WORCESTER, Mass. and TORONTO, June 13, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that the interview given by Dr. Elizabeth Mittendorf, M.D., Ph.D. to Oncology TV at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO) in respect of the Antigen Express (www.antigenexpress.com) AE37 breast cancer vaccine is now available on the Generex and Antigen Express websites, together with the abstracts related thereto.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One focuses on modification of peptides with Ii-Key to increase potency, while a second relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.gener
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
2. Interviews Of NW Bios CEO, On The Floor Of The New York Stock Exchange, Now Available Online
3. GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results
4. Breaking News: Video Interview With Harry Zhabilov of Immunotech Laboratories Inc.
5. Aethlon Medical Discloses CEO Interview
6. Mike Dixon Says the Job of Integrating Services is Far From Over in Interview on ITNs Healthcare Channel
7. Second Part of the Griffin Securities Analyst Interview with Unilife Corp. CEO is Now Available
8. Griffin Securities Analyst Interviews Unilife Corp. CEO in a Two-Part Video Series
9. GSK CEO Sir Andrew Witty Interviewed on Q2 2012 Results
10. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
11. A New Audio Interview With Ronald Adams President Of Medical Alarm Concepts Holding, Inc., Is Now At SmallCapVoice.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  DURECT Corporation (Nasdaq: DRRX ) ... successful completion of a Phase 1 clinical trial ... is an endogenous, small-molecule, new chemical entity (NCE), ... such as nonalcoholic fatty liver disease (NAFLD) and ... such as acute kidney injury (AKI).        ...
(Date:3/2/2015)... 2015  Intrexon Corporation (NYSE: XON ... its fourth quarter and full year results for ... Developments: , Acquired ActoGeniX, a European clinical ... cellular therapeutics and other innovative products.  Its proprietary ... microbes ( Lactococcus lactis ) to generate biologically-contained ...
(Date:3/2/2015)... DIEGO, March 2, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... quarter and full year ended December 31, 2014. Financial highlights ... a net loss of $5.3 million, or $0.04 per share. ... loss of $22.0 million, or $0.19 per share, for the ... 2014 include revenues of $75.3 million and a net loss ...
Breaking Medicine Technology:DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9
... N.J., April 7, 2011 C3i, the global leader ... industry and Oracle Gold Partner, announced today the opening ... operations center, located in the northern city of Dalian, ... including Chinese, Korean and Japanese, to sponsors and clinical ...
... 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... CSKI ), a leading fully integrated ... ("PRC"), today announced that the Company, jointly with ... production licenses for thirteen new medical products from ...
Cached Medicine Technology:C3i Opens Asia Language Center in Dalian, China 2China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products 2China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products 3
(Date:3/3/2015)... A newly launched program is available for the ... and pre-diabetes. As opposed to traditional pharmaceutical methods, Reverse ... sufferers to reverse their disease without the use of ... the U.S. diabetes industry made $250 billion from the ... use of insulin and other glucose-controlling medications that act ...
(Date:3/3/2015)... The physicians at Diet Doc have formulated ... that is being recommended by fast weight loss specialists ... that help people lose weight while improving the mood. ... thought to possess innovative solutions to the complexities of ... directed at targeting specific strategic points for fast ...
(Date:3/3/2015)... T-System Inc. today announced the ... FABC as the company’s chief nursing officer along with ... care. , “Today’s patients are demanding more ... urgent care and freestanding emergency centers one of the ... T-System’s chief executive officer. “We have a strong ...
(Date:3/3/2015)... FL (PRWEB) March 03, 2015 The ... segment which covers some great ideas when planning an ... but with an environmentally friendly approach. The segment will ... determine a hotel or resort’s sustainability policy, request Earth-friendly ... will also remind viewers about how to save electricity ...
(Date:3/3/2015)... Farms, MI (PRWEB) March 03, 2015 The ... is being held at the Ford Conference Center, Dearborn, MI, ... Information Technology, Inc., is a featured speaker. He is ... Of Big Data.” , These designations were earned due ... world’s 1st commercially-available NoSQL DB, released over 10 years ...
Breaking Medicine News(10 mins):Health News:New Breakthrough In Diabetes Reaserch Show Scientifically Proven Way To Reverse Your Diabetes Naturally In 30 Short Days 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 4Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3Health News:Forbes Living Segment on Planning an Eco-Vacation in the Works 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4
... any period of time after leaving the foster care ... than those with stable housing situations, according to a ... & Adolescent Medicine, one of the JAMA/Archives journals. Youth ... after leaving the foster care system appear to have ...
... 1 More than 125 leaders,from throughout the ... joined,together to support a multi-year, statewide campaign to ... campaign, launched by Nemours Health,and Prevention Services (NHPS), ... health professionals, parents, and other leaders to,improve the ...
... 1 In response to the,Supreme Court,s refusal to ... contraception from its health care coverage, Judie Brown,president of ... exercise of legislating via judicial fiat has reached new ... in defense of,religious organizations which do not want to ...
... Mylan Laboratories Inc.,(NYSE: MYL ) today announced the ... effective October 22, 2007. Mr. Byala joins Mylan,from Pfizer ... planning in both New York and Dublin. Mr. Byala ... positions of increasing responsibility.,Prior to Pfizer, Mr. Byala was ...
... Medical, Inc.,(Nasdaq: NXTM ), the manufacturer of ... announced that the Company has completed its,acquisition of ... million shares of NxStage common stock. "I ... place to realize the,significant opportunities that we see ...
... WASHINGTON, Oct. 1 A visionary leader, ... high-level recognition,for her outstanding contributions to the ... Americas during the 27th Pan American Sanitary ... Leadership in,Inter-American Health is bestowed upon creative ...
Cached Medicine News:Health News:Poor health care access common among youth leaving foster system 2Health News:Poor health care access common among youth leaving foster system 3Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 2Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 3Health News:Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer 2Health News:NxStage Medical Completes Acquisition of Medisystems 2Health News:NxStage Medical Completes Acquisition of Medisystems 3Health News:Inter-American Leadership Award Bestowed Upon Chilean Chronic Disease Expert 2
... leg bags are part of the ... line of leg bags, kits, and ... needs of our customers. These leg ... and constructed of 100% latex-free soft, ...
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
... leg bags are part of the ... line of leg bags, kits, and ... needs of our customers. These leg ... and constructed of 100% latex-free soft, ...
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
Medicine Products: